Login
Population (2005)
32.5m
GDP (PPP data, 2004)
$212.3bn
Health expenditure (2003)
Health expenditure as proportion of GDP (2003)
Size of pharmaceutical market (sales, 2001)
Proportion of GDP spent on pharmaceuticals (2001)
Percentage of health expenditure spent on medicines (2001)
Pharmaceutical market growth rate (2000)
Local currency
Algerian Dinar (DA)
Summary: Algeria
The quality of healthcare delivery in Algeria varies strongly from one region to another. A reform of the public sector is currently under consideration to consolidate the national healthcare provision and to ensure an appropriate coverage for the population. Hospital reform is a priority for the current authorities.
The principal characteristics of the Algerian pharmaceutical market are its relatively large size, its potential for growth and its high dependence on imported drugs.
Summary of report content
- Summary
- How is the healthcare system structured?
- What size is the pharmaceutical market?
- Are pharmaceuticals taxed?
- How are drug prices set?
- How are prices changed?
- How are drugs reimbursed?
- Is there a payback arrangement?
- Are hospital sales controlled?
- Are OTC prices regulated?
- How are pharmaceutical costs controlled?
- How are generic drugs priced?
- What are wholesale/pharmacy margins?
- Is parallel trade influential?
- What to look out for
- Glossary
- Useful Contacts
Your Basket
Your basket is currently empty.
Search News
News
25/04/2005
PhRMA asks for Algeria to be included in the 2005 Watch List
14/03/2005
Saidal imported banned drugs into Algeria, says manufacturer's association
Related Items